Project Grant K23DK144718
Award Date
8/1/25
Completion Date
7/31/30
Dollars Obligated
$191K
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $1,000,100 Cooperative Agreement to The General Hospital Corporation (doing business as Massachusetts General Hospital) on September 1, 2024. The award will fund a consortium to study gut-brain communication in Parkinson's disease (PD). Key objectives include: Contributing PD patients and healthy controls to a...
This $1,589,602 Cooperative Agreement awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will support a multidisciplinary study to investigate the role of altered gut immune response in Lewy body diseases (LBD), which include Parkinson's disease (PD) and dementia with Lewy bodies (DLB). The study aims to characterize peripheral involvement in PD and isolated REM sleep...
The U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1,227,232 Cooperative Agreement (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to Rush University Medical Center and partners to conduct a 5-year study on the gut-microbiota-brain axis in Parkinson's disease. The project will leverage existing and newly recruited patient cohorts to evaluate how disruptions in this biological axis contribute to Parkinson's disease severity...
This $475,605 Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to definitively evaluate gastric dysrhythmia as a disease mechanism underlying functional dyspepsia and chronic nausea/vomiting syndromes, which affect over 10% of the population. The project will apply a novel non-invasive diagnostic approach called Body...
The Mayo Clinic Consortium for Gut Brain Communication in Parkinson's Disease is a cooperative agreement awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $1,210,498 award will fund a 5-year research project to investigate the underlying mechanisms and biomarkers linking gastrointestinal symptoms, especially constipation, to the development of Parkinson's...
This Cooperative Agreement award of $1,722,000.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) supports a cross-sectional and longitudinal study of gut microbiota in Parkinson's disease (PD). The research team at the University of Chicago will conduct studies to gain a better understanding of the role of gut dysbiosis in the development, progression, and prognosis...
This Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $2,763,167 to Duke University over 5 years starting August 15, 2024. The award will fund the establishment of the Gut Brain Parkinson's Disease Consortium (GBPDC) Coordinating and Data Management Center (CDMC) to build an annotated biospecimen repository and support the...
This federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $747,500.00 to support research on memory formation in the enteric nervous system (ENS). The project aims to build the tools required for studying the formation and meaning of ENS memories, and then use these tools in combination with various perturbations to transform the...
This $475,475 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts. The goal of the award is to evaluate a small molecule inhibitor of the USP30 enzyme as a potential neuroprotective therapy for Parkinson's disease. The research will assess...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $882,538 to Washington University to investigate the role of the Parkinson's disease-associated gene LRRK2 in regulating gut epithelial homeostasis. The key products and services delivered under this award include: Examining how autophagy deficiency and cigarette smoking activate LRRK2...